4-s-(propionic acid)sulfidocyclophosphamide has been researched along with Lung Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erickson, LC; Ramonas, LM; Ringsdorf, H; Zaharko, DS | 1 |
1 other study(ies) available for 4-s-(propionic acid)sulfidocyclophosphamide and Lung Neoplasms
Article | Year |
---|---|
Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Lung Neoplasms; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental | 1980 |